论文信息 - Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center. - 字舞流文

Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.

B. Zanker | W. Land | U. Rothenpieler | W. Illner | G. Hillebrand | H. Schneeberger

[1] D Talbot,et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. , 1997, Transplantation.

[2] M. Christiaans,et al. FK 506 versus cyclosporin in the prevention of renal allograft rejection – European pilot study: six‐week results , 1995, Transplant international : official journal of the European Society for Organ Transplantation.

[3] A. Matas,et al. Phase II FK 506 multicenter concentration control study: one-year follow-up. , 1995, Transplantation proceedings.

[4] S. Todo,et al. Kidney transplantation under FK 506 immunosuppression. , 1991, Transplantation proceedings.